Liliana Czornyj
Overview
Explore the profile of Liliana Czornyj including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
115
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Czornyj L, Auzmendi J, Lazarowski A
Epilepsia Open
. 2021 Sep;
7 Suppl 1:S34-S46.
PMID: 34542938
The multidrug-resistance (MDR) phenotype is typically observed in patients with refractory epilepsy (RE) whose seizures are not controlled despite receiving several combinations of more than two antiseizure medications (ASMs) directed...
2.
Czornyj L, Guido P, Bramuglia G, Rodino A, Feria-Romero I, Lazarowski A
Epilepsy Res
. 2018 Oct;
148:107-114.
PMID: 30279018
Background: Low levels of AEDs can be secondary drug-drug interactions or related to irregular intake due to poor treatment adherence. This latter behavior is highly suspected in ambulatory pediatric epileptic...
3.
Merelli A, Czornyj L, Lazarowski A
Curr Pharm Des
. 2013 Mar;
19(38):6791-801.
PMID: 23530506
Neuronal damage secondary to brain injuries such as cerebral hypoxia, seizures as well as neurodegenerative process, may include pro-inflammatory changes. The activation of a common mechanism related to survival or...
4.
Lazarowski A, Czornyj L
Drug Metabol Drug Interact
. 2011 May;
26(1):21-6.
PMID: 21557674
Epilepsy is a common neurological disorder. About one-third of epilepsy patients have a multidrug resistance (MDR) phenotype and develop refractory epilepsy (RE). Changes in the properties of the antiepileptic drugs...
5.
Lazarowski A, Czornyj L, Lubienieki F, Girardi E, Vazquez S, Dgiano C
Epilepsia
. 2007 Oct;
48 Suppl 5:140-9.
PMID: 17910594
It is estimated 20-25% of the epileptic patients fails to achieve good control with the different antiepileptic drugs (AEDs) treatments, developing refractory epilepsy (RE). Discovered first in cancer, the activity...